Effect of granisetron on performance status during high-dose interferon therapy

Oncology

Volumn 57, Issue 4, 1999, Pages 303-305

  Drapkin, Robert ^a   Barolo, Jennifer L ^a   Blower, Peter R ^b  

^a Florida Community Cancer Center   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Fatigue; Granisetron; Interferon; Performance status

Indexed keywords

GRANISETRON; RECOMBINANT INTERFERON;

ADULT; ARTICLE; CANCER; CASE REPORT; DRUG TOXICITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VOMITING;

EID: 0032700755     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012065     Document Type: Article

References (13)

1. Miner WD, Sanger GJ: Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol 1986;88:497-499.
2. Gralla RJ: The clinical approach to chemotherapy-induced emesis; in Reynolds DJM, Andrews PLR, Davis CJ (eds): Serotonin and the Scientific Basis of Anti-Emetic Therapy. Oxford, Oxford Clinical Communications, 1995, pp 60-67.
3. Andrews PLR, Davis CJ: The physiology of emesis induced by anti-cancer therapy; in Reynolds DJM, Andrews PLR, Davis CJ (eds): Serotonin and the Scientific Basis of Anti-Emetic Therapy. Oxford, Oxford Clincal Communications, 1995, pp 25-49.
4. Andrews PLR, Davis CJ, Bingham S, Davidson HI, Hawthorn J, Maskell L: The abdominal visceral innervation and the emetic reflex: Pathways, pharmacology, and plasticity. Can J Physiol Pharmacol 1990;68:325-345.
5. Minami M, Endo T, Nemoto M, Hamaue N, Hirafuji M, Monoma Y, Yajima T, Yoshioka M, Saito H: How do toxic emetic stimuli cause 5-HT release in the gut and brain?; in Reynolds DJM, Andrews PLR, Davis CJ (eds): Serotonin and the Scientific Basis of Anti-Emetic Therapy. Oxford, Oxford Clinical Communications, 1995, pp 68-76.
6. Andrews PLR, Davis CJ: The mechanism of emesis induced by anti-cancer therapies; in Andrews PLR, Sanger GJ (eds): Emesis in Anti-Cancer Therapy: Mechanisms and Treatment. London, Chapman & Hall Medical, 1993, pp 113-161.
7. Matsuki N, Nakajima S, Saito H: The role of free radicals and nitric oxide in the induction of emesis; in Reynolds DJM, Andrews PLR, Davis CJ (eds): Serotonin and the Scientific Basis of Anti-Emetic Therapy. Oxford, Oxford Clinical Communications, 1995, pp 77-83.
8. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman LS, Gilman A: Goodman and Gilman's the Pharmacological Basis of Therapeutics, ed 9. New York, McGraw-Hill, 1996, chap 10, 11.
9. Bianchi GP, Grossi G, Bargossi AM: May peripheral and central fatigue be correlated? Can we monitor them by means of clinical laboratory tools? J Sports Med Phys Fitness 1997;37: 194-199.
10. Blomstrand E, Celsing F, Newsholme EA: Changes in plasma concentrations of aromatic and branched-chain amino acids during sustained exercise in man and their possible role in fatigue. Acta Physiol Scand 1988;133:115-121.
11. Acworth I, Nicholass J, Morgan B, Newsholme EA: Effect of sustained exercise on concentration of plasma aromatic and branched-chain amino acids and brain amines. Biochem Biophys Res Commun 1986;137:149-153.
12. Andrews PLR, Blower PR: Communication at a satellite symposium of the 10th Multinational Association of Supportive Care in Cancer Meeting, San Antonio, 1998.
13. Hayden FG: Antiviral agents; in Hardam JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman LS, Gilman A (eds): Goodman and Gilman's the Pharmacological Basis of Therapeutics, ed 9. New York, McGraw-Hill, 1996, pp 1191-1223.